Name | Number of supported studies | Average coverage | |
---|---|---|---|
myofibroblast cell | 4 studies | 30% ± 10% | |
capillary endothelial cell | 3 studies | 26% ± 5% |
Insufficient scRNA-seq data for expression of SOSTDC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 92% | 362.66 | 884 / 966 | 55% | 6.97 | 288 / 527 |
lung | 97% | 1257.78 | 559 / 578 | 48% | 19.71 | 556 / 1155 |
stomach | 89% | 827.96 | 321 / 359 | 48% | 7.90 | 136 / 286 |
kidney | 89% | 348.30 | 79 / 89 | 42% | 83.77 | 376 / 901 |
esophagus | 52% | 92.57 | 752 / 1445 | 59% | 23.11 | 108 / 183 |
skin | 72% | 734.19 | 1296 / 1809 | 33% | 24.73 | 158 / 472 |
breast | 57% | 449.73 | 260 / 459 | 38% | 10.05 | 423 / 1118 |
ovary | 11% | 11.07 | 20 / 180 | 53% | 14.19 | 229 / 430 |
thymus | 54% | 117.87 | 355 / 653 | 10% | 0.85 | 59 / 605 |
bladder | 33% | 108.76 | 7 / 21 | 25% | 5.13 | 126 / 504 |
prostate | 34% | 46.71 | 83 / 245 | 17% | 1.02 | 84 / 502 |
brain | 31% | 88.38 | 828 / 2642 | 13% | 1.06 | 94 / 705 |
tonsil | 0% | 0 | 0 / 0 | 36% | 9.44 | 16 / 45 |
heart | 34% | 100.13 | 290 / 861 | 0% | 0 | 0 / 0 |
pancreas | 1% | 1.00 | 3 / 328 | 31% | 4.33 | 56 / 178 |
uterus | 3% | 10.81 | 5 / 170 | 28% | 8.66 | 129 / 459 |
eye | 0% | 0 | 0 / 0 | 25% | 3.43 | 20 / 80 |
adrenal gland | 3% | 3.86 | 9 / 258 | 6% | 1.01 | 14 / 230 |
liver | 0% | 0 | 0 / 226 | 7% | 0.80 | 29 / 406 |
adipose | 6% | 11.15 | 72 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 4% | 5.85 | 56 / 1335 | 0% | 0 | 0 / 0 |
muscle | 1% | 1.93 | 12 / 803 | 0% | 0 | 0 / 0 |
spleen | 1% | 1.59 | 2 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042475 | Biological process | odontogenesis of dentin-containing tooth |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
GO_0031069 | Biological process | hair follicle morphogenesis |
GO_0045662 | Biological process | negative regulation of myoblast differentiation |
GO_0072148 | Biological process | epithelial cell fate commitment |
GO_0060648 | Biological process | mammary gland bud morphogenesis |
GO_2000016 | Biological process | negative regulation of determination of dorsal identity |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0007389 | Biological process | pattern specification process |
GO_0010454 | Biological process | negative regulation of cell fate commitment |
GO_0005615 | Cellular component | extracellular space |
GO_0098821 | Molecular function | BMP receptor activity |
GO_0036122 | Molecular function | BMP binding |
Gene name | SOSTDC1 |
Protein name | Sclerostin domain-containing protein 1 Sclerostin domain-containing protein 1 (Ectodermal BMP inhibitor) (Ectodin) (Uterine sensitization-associated gene 1 protein) (USAG-1) |
Synonyms | tcag7.902 CDA019 hCG_19295 USAG1 |
Description | FUNCTION: May be involved in the onset of endometrial receptivity for implantation/sensitization for the decidual cell reaction Enhances Wnt signaling and inhibits TGF-beta signaling (By similarity). Directly antagonizes activity of BMP2, BMP4, BMP6 and BMP7 in a dose-dependent manner. . |
Accessions | Q6X4U4 ENST00000307068.5 [Q6X4U4-1] ENST00000396652.1 [Q6X4U4-2] A4D125 |